Indivumed

About:

A Hamburg,Germany-based physician-led, integrated global oncology company.

Website: http://www.indivumed.com/

Top Investors: European Investment Bank

Description:

Indivumed was founded in Hamburg, Germany in 2002 with one main driver – the individualization of cancer therapy through the generation, characterization, and analysis of biologic samples from human cancer patients. Since then, the company has expanded globally, with a subsidiary in the USA, partnerships with leading cancer clinics in Europe, the US and Asia and more than 50 oncology practices located in Germany, and, finally, more than 100 biopharma industry partners – and a global reputation for product and service quality.

Total Funding Amount:

40M EUR

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Germany, Georgia, United States

Founded Date:

2002-01-01

Contact Email:

info-eu(AT)indivumed.com

Founders:

Hartmut Juhl

Number of Employees:

101-250

Last Funding Date:

2018-01-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai